← Back to Clinical Trials
Recruiting NCT06041763

Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair

Trial Parameters

Condition Meniscus Tear
Sponsor NYU Langone Health
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2024-11-20
Completion 2026-11
Interventions
Meniscal Repair ProcedureBEAR Implant

Brief Summary

The bridge-enhanced ACL repair (BEAR) implant is a collagen-based scaffold loaded with whole blood. It is designed to promote healing in the setting of intraarticular knee pathology. This study would compare clinical outcomes and synovial fluid cytokine profiles in patients who undergo isolated meniscal repair with or without the BEAR implant.

Eligibility Criteria

Inclusion Criteria: • History of meniscus injury indicated for isolated repair, without concomitant ligament reconstruction or repair, cartilage repair procedure, or osteotomy. Exclusion Criteria: * Patients who are undergoing meniscal repair for displaced bucket-handle meniscal tears * Patients with a history of blood-borne diseases including HIV, hepatitis B virus, hepatitis C virus, human T-lymphotropic virus, and syphilis

Related Trials